Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,173,873 papers from all fields of science
Search
Sign In
Create Free Account
CDB 2914
Known as:
CDB-2914
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
ulipristal
ulipristal acetate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Novel hormone treatment of benign metastasizing leiomyoma: an analysis of five cases and literature review.
E. Lewis
,
R. Chason
,
A. Decherney
,
A. Armstrong
,
J. Elkas
,
A. Venkatesan
Fertility and sterility
2013
Corpus ID: 4574020
Highly Cited
2008
Highly Cited
2008
CDB-2914 for Uterine Leiomyomata Treatment: A Randomized Controlled Trial
E. Levens
,
C. Potlog-Nahari
,
+5 authors
L. Nieman
Obstetrics and gynecology
2008
Corpus ID: 13776635
OBJECTIVE: To evaluate whether 3-month administration of CDB-2914, a selective progesterone receptor modulator, reduces leiomyoma…
Expand
Review
2008
Review
2008
Interventions for emergency contraception.
L. Cheng
,
A. Gülmezoĝlu
,
G. Piaggio
,
E. Ezcurra
,
P. V. Van Look
The Cochrane database of systematic reviews
2008
Corpus ID: 973355
BACKGROUND Emergency contraception is using a drug or copper intrauterine device (Cu-IUD) to prevent pregnancy shortly after…
Expand
Highly Cited
2008
Highly Cited
2008
Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells.
Qin-Yang Xu
,
N. Ohara
,
+4 authors
T. Maruo
Molecular human reproduction
2008
Corpus ID: 17957832
Effects of progesterone receptor modulator CDB-2914 on the expression of the extracellular matrix (ECM) components were examined…
Expand
Highly Cited
2006
Highly Cited
2006
Progesterone receptor modulator CDB-2914 down-regulates vascular endothelial growth factor, adrenomedullin and their receptors and modulates progesterone receptor content in cultured human uterine…
Qin-Yang Xu
,
N. Ohara
,
+6 authors
T. Maruo
Human reproduction
2006
Corpus ID: 2748309
BACKGROUND This study was conducted to evaluate the effects of graded concentrations (10(-8), 10(-7) and 10(-6) M) of…
Expand
Highly Cited
2006
Highly Cited
2006
Inhibition of Proliferation of Endometrial Stromal Cells by Trichostatin A, RU486, CDB-2914, N-Acetylcysteine, and ICI 182780
Yan Wu
,
Sun‐Wei Guo
Gynecologic and Obstetric Investigation
2006
Corpus ID: 38586306
Background: All current major medications in treating endometriosis are effective in treating pain, most likely through…
Expand
Highly Cited
2005
Highly Cited
2005
Progesterone receptor modulator CDB-2914 down-regulates proliferative cell nuclear antigen and Bcl-2 protein expression and up-regulates caspase-3 and poly(adenosine 5'-diphosphate-ribose) polymerase…
Qin-Yang Xu
,
S. Takekida
,
+4 authors
T. Maruo
The Journal of clinical endocrinology and…
2005
Corpus ID: 1614671
The present study was conducted to evaluate the effects of the progesterone receptor modulator CDB-2914 on proliferative activity…
Expand
2003
2003
Luteal phase dose-response relationships of the antiprogestin CDB-2914 in normally cycling women.
M. Passaro
,
J. Piquion
,
+5 authors
L. Nieman
Human reproduction
2003
Corpus ID: 20872933
BACKGROUND Progesterone receptor modulators have potential therapeutic use in progesterone-dependent conditions such as…
Expand
Highly Cited
2000
Highly Cited
2000
A single mid-follicular dose of CDB-2914, a new antiprogestin, inhibits folliculogenesis and endometrial differentiation in normally cycling women.
P. Stratton
,
B. Hartog
,
+5 authors
L. Nieman
Human reproduction
2000
Corpus ID: 21497109
Previous studies in women have shown that the antiprogestin mifepristone delays or inhibits folliculogenesis. The purpose of this…
Expand
Highly Cited
2000
Highly Cited
2000
CDB-2914: anti-progestational/anti-glucocorticoid profile and post-coital anti-fertility activity in rats and rabbits.
S. Hild
,
J. Reel
,
L. Hoffman
,
R. Blye
Human reproduction
2000
Corpus ID: 815722
Our goal was to determine the endocrine and post-coital anti-fertility activity of CDB-2914. Concurrent administration of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE